Epithelioid sarcoma: Need for a multimodal approach to maximize the chances of curative conservative treatment

Annals of Surgical Oncology

Volumn 21, Issue 1, 2014, Pages 269-276

  Levy, Antonin ^a   Le Péchoux, Cécile ^a   Terrier, Philippe ^a   Bouaita, Ryan ^a   Domont, Julien ^a   Mir, Olivier ^a   Coppola, Sarah ^a   Honoré, Charles ^a   Le Cesne, Axel ^a   Bonvalot, Sylvie ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHILD; COMORBIDITY; CONSERVATIVE TREATMENT; DISEASE COURSE; EPITHELIOID SARCOMA; FEMALE; FOLLOW UP; HUMAN; IN-TRANSIT METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PRESCHOOL CHILD; SCHOOL CHILD; SURVIVAL RATE; TUMOR VOLUME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SARCOMA; SURVIVAL RATE; YOUNG ADULT;

EID: 84891745026     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3247-4     Document Type: Article

References (37)

1. Mastrangelo G, Coindre JM, Ducimetière F, et al. Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions. Cancer. 2012;118:5339-48.
2. Laskowski J. Sarcoma aponeuroticum. Nowotory. 1961;11:61-7.
3. Enzinger FM. Epitheloid sarcoma. A sarcoma simulating a granuloma or a carcinoma. Cancer. 1970;26:1029-41.
4. Armah HB, Parwani AV. Epithelioid sarcoma. Arch Pathol Lab Med. 2009;133:814-9.
5. Dei Tos AP, Wagner AJ, Modena P, et al. Epithelioid soft tissue tumors. Semin Oncol. 2009; 36:347-57.
6. Spillane AJ, Thomas JM, Fisher C. Epithelioid sarcoma: the clinicopathological complexities of this rare soft tissue sarcoma. Ann Surg Oncol. 2000;7:218-25.
7. de Visscher SA, van Ginkel RJ, Wobbes T, et al. Epithelioid sarcoma: still an only surgically curable disease. Cancer. 2006;107:606-12.
8. Zagars GK, Ballo MT, Pisters PW, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1,225 patients. Cancer. 2003; 97:2530-43.
9. ESMO/European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23S:vii92-9.
10. Kraybill WG, Harris J, Spiro IJ, et al. Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514. Cancer. 2010;116:4613-21.
11. Grunhagen DJ, de Wilt JH, Graveland WJ, et al. Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma. Cancer. 2006;106:1776.
12. Bonvalot S, Laplanche A, Lejeune F, Stoeckle E, Le Péchoux C, Vanel D, Terrier P, Lumbroso J, Ricard M, Antoni G, Cavalcanti A, Robert C, Lassau N, Blay JY, Le Cesne A. Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-alpha be better? Ann Oncol. 2005;16:1061-8.
13. Bonvalot S, Rimareix F, Causeret S, et al. Hyperthermic isolated limb perfusion in locally advanced soft tissue sarcoma and progressive desmoid-type fibromatosis with TNF 1 mg and melphalan (T1-M HILP) is safe and efficient. Ann Surg Oncol. 2009;16:3350.
14. McGee L, Indelicato DJ, Dagan R, et al. Long-term results following postoperative radiotherapy for soft tissue sarcomas of the extremity. Int J Radiat Oncol Biol Phys. 2012;84:1003-9.
15. Shimm DS, Suit HD. Radiation therapy of epithelioid sarcoma. Cancer. 1983;52:1022-5.
16. Wolf PS, Flum DR, Tanas MR, et al. Epithelioid sarcoma: The University of Washington experience. Am J Surg. 2008;196:407-12.
17. Callister MC, Ballo MT, Pisters PWT, et al. Epithelioid sarcoma: results of conservative surgery and radiotherapy. Int J Rad Oncol Biol Phys. 2001;51:384-91.
18. Baratti D, Pennacchioli E, Casali PG, et al. Epithelioid sarcoma: prognostic factors and survival in a series of patients treated at a single institution. Ann Surg Oncol. 2007;14:3542-51.
19. Edge SB, Byrd DR, Compton CC, et al. Soft tissue sarcoma. AJCC cancer staging manual, 7th edn. New York: Springer, 2010, pp 291-6.
20. Enzinger FM, Weiss SW. Soft tissue tumors, III edn. St. Louis: Mosby, 1994.
21. Trojani M, Contesso G, Coindre JM, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer. 1984;33:37-42.
22. Tumor of bone and soft tissues. R classification. In: Sobin LH, Wittekind Ch. TNM classification of malignant tumours UICC, 6th edn, 2002. New York: Wiley Liss, p 110.
23. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205-16.
24. Ross HM, Lewis JJ, Woodruff JM, et al. Epithelioid sarcoma: clinical behavior and prognostic factors of survival. Ann Surg Oncol. 1997;4:491-5.
25. Guzzetta AA, Montgomery EA, Lyu H, et al. Epithelioid sarcoma: one institution's experience with a rare sarcoma. J Surg Res. 2012;177:116-22.
26. Halling AC, Wollan PC, Pritchard DJ, et al. Epithelioid sarcoma: a clinicopathologic review of 55 cases. Mayo Clin Proc. 1996;71:636-42.
27. Grunhagen DJ, de Wilt JH, Graveland WJ, et al. Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma. Cancer. 2006;106:1776.
28. Deroose JP, van Geel AN, Burger JW, et al. Isolated limb perfusion with TNF-alpha and melphalan for distal parts of the limb in soft tissue sarcoma patients. J Surg Oncol. 2012;105:563-9.
29. Olofsson R, Bergh P, Berlin O, et al. Long-term outcome of isolated limb perfusion in advanced soft tissue sarcoma of the extremity. Ann Surg Oncol. 2012;19:1800-7.
30. Bonvalot S, Dunant A, Le Pechoux C, et al. Quality of surgical margins and local recurrence in primary extremity soft tissue sarcoma (STS). J Clin Oncol. 2010;28:15s (suppl; abstr 10068).
31. Pennacchioli E, Deraco M, Mariani L, Fiore M, Mussi C, Collini P, Olmi P, Casali PG, Santinami M, Gronchi A. Advanced extremity soft tissue sarcoma: prognostic effect of isolated limb perfusion in a series of 88 patients treated at a single institution. Ann Surg Oncol. 2007;14:553-9.
32. Stoeckle E, Gardet H, Coindre JM, Kantor G, Bonichon F, Milbéo Y, Thomas L, Avril A, Bui BN. Prospective evaluation of quality of surgery in soft tissue sarcoma. Eur J Surg Oncol. 2006;32:1242-8.
33. Bhangu A, Broom L, Nepogodiev D, Gourevitch D, Desai A. Outcomes of isolated limb perfusion in the treatment of extremity soft tissue sarcoma: a systematic review. Eur J Surg Oncol. 2013;39:311-9.
34. Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS. Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy. Cancer. 2003;97:2544-53.
35. Steinberg BD, Gelberman RH, Mankin HJ, et al. Epithelioid sarcoma in the upper extremity. J Bone Joint Surg. 1992;74:28-35.
36. Maduekwe UN, Hornicek FJ, Springfield DS, et al. Role of sentinel lymph node biopsy in the staging of synovial, epithelioid, and clear cell sarcomas. Ann Surg Oncol. 2009;16:1356-63.
37. Xie X, Ghadimi MP, Young ED, et al. Combining EGFR and mTOR blockade for the treatment of epithelioid sarcoma. Clin Cancer Res. 2011;17:5901-12.